Skip to main content
Top
Published in:

Open Access 01-12-2023 | Biomarkers | Research

Use of the RCOG risk assessment model and biomarkers to evaluate the risk of postpartum venous thromboembolism

Authors: Hua Li, Sheng Wan, Jindan Pei, Lu Zhang, Jing Peng, Ronghua Che

Published in: Thrombosis Journal | Issue 1/2023

Login to get access

Abstract

Background

Venous thromboembolism (VTE) is a leading cause of morbidity and mortality during pregnancy and the puerperium. The vast majority of VTE occurs after childbirth. China has not yet established standard risk assessment model for postpartum venous thromboembolism (VTE), the Royal College of Obstetricians and Gynecologists (RCOG) risk assessment model (RAM) is commonly used in clinic at present. Herein, we aimed to evaluate the validity of the RCOG RAM in the Chinese population and try to formulate a local risk assessment model by combining with other biomarkers for VTE prophylaxis.

Methods

The retrospective study was conducted from January 2019 to December 2021at Shanghai First Maternity and Infant Hospital which has approximately 30,000 births annually, and the incidence of VTE, differences between RCOG-recommended risk factors, and other biological indicators from medical records were evaluated.

Results

The study included VTE (n = 146) and non-VTE(n = 413) women who examined by imaging for suspicion of postpartum VTE. There was no statistical difference in the incidence rate of postpartum VTE between the low-score group (23.8%) and the high-score group (28%) after stratification by RCOG RAM. However, we found that cesarean section (in the low-score group), white blood cell (WBC) ≥ 8.64*10^9/L (in the high-score group), low-density lipoprotein(LDL) ≥ 2.70 mmol/L, and D-dimer ≥ 3.04 mg/L (in both groups) were highly associated with postpartum VTE. Subsequently, the validity of the RCOG RAM combined with biomarkers as a model for the risk assessment of VTE was estimated and the results showed that this model has good accuracy, sensitivity, and specificity.

Conclusions

Our study indicated that the RCOG RAM was not the best strategy for predicting postpartum VTE. Combined with some biomarkers (including the value of LDL and D-Dimer, and WBC count), the RCOG RAM is more efficient when identifying high-risk groups of postpartum VTE in the Chinese population.

Trial registration

This purely observational study does not require registration based on ICMJE guidelines.
Appendix
Available only for authorised users
Literature
5.
go back to reference Royal College of Obstetricians and Gynaecologists. Reducing the risk of venous thromboembolism during pregnancy and the Puerperium: Green-top Guideline No. 37a. 2015. Royal College of Obstetricians and Gynaecologists. Reducing the risk of venous thromboembolism during pregnancy and the Puerperium: Green-top Guideline No. 37a. 2015.
28.
29.
go back to reference The National Institute for Health and Care Excellence. Guidelines: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing.2020. The National Institute for Health and Care Excellence. Guidelines: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing.2020.
33.
go back to reference Gonzalez-Ordonez AJ, Fernandez-Carreira JM, Fernandez-Alvarez CR, Venta Obaya R, Macias-Robles MD. Gonzalez-Franco A and Arias Garcia M A. The concentrations of soluble vascular cell adhesion molecule-1 and lipids are independently associated with venous thromboembolism. Haematologica. 2003;88:1035–43.PubMed Gonzalez-Ordonez AJ, Fernandez-Carreira JM, Fernandez-Alvarez CR, Venta Obaya R, Macias-Robles MD. Gonzalez-Franco A and Arias Garcia M A. The concentrations of soluble vascular cell adhesion molecule-1 and lipids are independently associated with venous thromboembolism. Haematologica. 2003;88:1035–43.PubMed
34.
35.
go back to reference Galeano-Valle F, Ordieres-Ortega L, Oblitas CM, Del-Toro-Cervera J, Alvarez-Sala-Walther L, Demelo-Rodriguez P. Inflammatory biomarkers in the short-term prognosis of venous thromboembolism: a narrative review. Int J Mol Sci. 2021;22. https://doi.org/10.3390/ijms22052627. Galeano-Valle F, Ordieres-Ortega L, Oblitas CM, Del-Toro-Cervera J, Alvarez-Sala-Walther L, Demelo-Rodriguez P. Inflammatory biomarkers in the short-term prognosis of venous thromboembolism: a narrative review. Int J Mol Sci. 2021;22. https://​doi.​org/​10.​3390/​ijms22052627.
39.
go back to reference Hoke M, Kyrle PA, Philipp K, Pabinger I, Kaider A, Schonauer V, Quehenberger P, Eichinger S. Prospective evaluation of coagulation activation in pregnant women receiving low molecular weight heparin. Thromb Haemost. 2004;91:935–40.CrossRefPubMed Hoke M, Kyrle PA, Philipp K, Pabinger I, Kaider A, Schonauer V, Quehenberger P, Eichinger S. Prospective evaluation of coagulation activation in pregnant women receiving low molecular weight heparin. Thromb Haemost. 2004;91:935–40.CrossRefPubMed
42.
go back to reference Roth 1 GJ, Calverley DC. Aspirin, platelets, and thrombosis: theory and practice. Blood 1994 Feb 15;83(4):885–98. Roth 1 GJ, Calverley DC. Aspirin, platelets, and thrombosis: theory and practice. Blood 1994 Feb 15;83(4):885–98.
Metadata
Title
Use of the RCOG risk assessment model and biomarkers to evaluate the risk of postpartum venous thromboembolism
Authors
Hua Li
Sheng Wan
Jindan Pei
Lu Zhang
Jing Peng
Ronghua Che
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Biomarkers
Published in
Thrombosis Journal / Issue 1/2023
Electronic ISSN: 1477-9560
DOI
https://doi.org/10.1186/s12959-023-00510-6

Other articles of this Issue 1/2023

Thrombosis Journal 1/2023 Go to the issue

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more